Scott Schliebner has recently joined TFS as Senior Vice President, Clinical Development Services. Based in the US, Scott brings more than 25 years of clinical drug development expertise to TFS, having worked across the biotech, non-profit, small CRO, and large global CRO sectors. Scott will head up the Pediatric, Rare and Orphan Disease Business Unit … Continued
We are excited to announce that we are strengthening our presence with the brand-new office in central London, in addition to the Uxbridge location. The office provides a modern and flexible workspace allowing our team to work in a hybrid model as well as full-time from the office. Since March 2020, we have all had … Continued
TFS HealthScience is excited to announce the appointment of Julia Day as Executive Director and Global Head of Business Development for Clinical Development Services (CDS). Julia is a high-performing leader in the biopharmaceutical industry, bringing over 30 years of sales, marketing and customer management experience in diverse life science companies. Her success in high-value, complex programs with senior decision makers has made … Continued
Strategic growth in the region brings TFS, a leading mid-size global CRO, to Research Triangle Park (RTP) to support an increasing demand for tailored and flexible solutions among the biotech and pharma customers. The Durham office further expands the company’s presence across North America and follows partnership with local customers. RTP, otherwise called Research Triangle, … Continued
TFS HealthScience, a global mid-size CRO, announced that Eva Brike has joined the company as Chief People Officer. Eva will lead all areas of human resources, and talent strategy, including employee experience, as well as communications for the growing team of over 700 professionals at TFS. The CPO is a new role at TFS and … Continued
TFS HealthScience has announced the appointment of Jesper Hjort as Chief Financial Officer. Joining from FLSmidth, a listed engineering company, Jesper brings over 14 years of finance experience across financial reporting, governance, risk management and forecasting as well as accounting and auditing. He has spent several years working in companies operating globally. Bassem Saleh, TFS … Continued
This accreditation enables TFS to address complex requirements characteristic of the current clinical research environment. Flexible approach and quick implementation of change helps us reach our clinical trial goals. As Medidata partner we are able to provide scalable solutions and create a complete value-driven experience for our biopharma customers. “The accreditation in Medidata Balance® grows our portfolio … Continued
TFS has launched Connectify, a much-awaited Expert and Talent Network TFS is expanding its solutions offering to provide leadership, subject matter expertise and talent to our customers in the health science industry. This new service is underpinned by TFS’ contract research expertise, sound industry reputation and drive to meet the unmet needs of patients. Through … Continued
Veeva Vault unifies clinical documents and processes to improve collaboration and speed execution Veeva Systems (NYSE: VEEV) today announced that TFS HealthScience will be the first CRO to have selected Veeva Vault Clinical Operations Suite for end-to-end study management on a single cloud platform. The European-headquartered global CRO is taking action to further modernize the study operations, adopting the entire suite … Continued
TFS is pleased to announce the appointment of René Holmen Pedersen as Chief Financial Officer. He will begin his employment on March 1, 2021 and will be based out of TFS global headquarters in Lund. “We are excited to have Rene join TFS. He complements our strong performance-oriented culture and his impressive reputation for strategy, … Continued
